Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
The U.S. company, Medical Device King (also known as Pharmalogical) has distributed a cancer medicine that was not approved by the FDA (Food and Drug Administration) FDA lab tests confirm that at least one batch of a counterfeit version of Roche’s Altuzan (bevacizumab) contains no active ingredient. Aluzan, an injectable cancer medicine, is not approved [...]
Counterfeit Avastin Marketed as Altuzan in US The FDA has uncovered another batch of counterfeit cancer drug Avastin reports The Wall Street Journal. The fakes have been packaged in Altuzan packaging, which is the Turkish name for Avastin. “Patients receiving cancer drugs or other drugs not approved by the FDA for the U.S. market may [...]
On its front page, the Wall Street Journal (3/7, A1, Whalen, Faucon, Subscription Publication) reports that, according to investigators and documents it has examined, authorities looking into the importation of low cost foreign drugs into the US have linked a Canadian drug supplier that may have shipped the counterfeit bevacizumab [Avastin] into the US. Federal officials are [...]
Avastin, one of the world’s most popular cancer drugs, has been under intense scrutiny by the FDA while the agency works to determine whether or not to pull its approval of the drug as a treatment for breast cancer. In an effort to save one of its best-selling products, the drug’s manufacturer, Roche, has asked [...]
According to the results of a new study, use of the popular cancer drug, Avastin, could potentially affect fertility in some women. Based on the data, the U.S. Food and Drug Administration ordered the drug’s label be updated to reflect the risk for ovarian failure, as well as the risk for additional adverse events, such [...]
The U.S. Department of Veterans Affairs this week announced that it has discontinued its use of Roche’s popular drug, Avastin, as a treatment for eye disease, pending the results of an investigation into the safety and efficacy of the drug when used for ophthalmologic purposes. The VA’s decision to drop the drug was ultimately based [...]
Roche’s best-selling cancer drug, Avastin, is currently the subject of an unprecedented hearing set to take place this week. Federal regulators have scrutinized the once-promising drug after it proved to carry more risks than benefits in patients taking the medication as a treatment for breast cancer. In fact, the U.S. Food and Drug Administration granted [...]
